Abstract:OBJECTIVE:To identify the novel genetic defects in patients with congenital ventricular septal defect (VSD).METHODS:The clinical data and blood samples from 160 unrelated subjects with congenital VSD were collected and evaluated in comparison with 200 healthy individuals. The coding exons and flanking introns of NKX2-5 gene were amplified by polymerase chain reaction and sequenced using the di-deoxynucleotide chain termination approach. The acquired sequences were aligned with those publicized in GenBank by the aid of program BLAST to identify the sequence variations. The software Clustal W was applied to analyzing the conservation of altered amino acids.RESULTS:Two novel heterozygous missense NKX2-5 mutations were identified in 3 of 160 VSD patients. The same triplet substitution of TTC for TCC at codon 179, predicting the conversion of serine into phenylalanine at amino acid residue 179 (Ser179Phe), was detected in two cases. Another transition of CGC into AGC at codon 36, leading to the change of arginine into serine at amino acid residue 36 (Arg36Ser), was detected in a third case. These two mutations were not observed in 200 healthy controls. A cross-species alignment of NKX2-5 encoded protein sequences displayed that the mutated amino acids were highly conserved evolutionarily. Additionally, two single nucleotide polymorphisms including a common c. 63A > G and a rare c. 606G > C were observed. However, the polymorphic frequency distributions in VSD cases were not statistically different from those in healthy controls (c. 63A > G: chi(2) = 3.403, P = 0.0651; c. 606G > C: chi(2) = 3.278, P = 0.0702).CONCLUSION:Novel NKX2-5 mutations are identified in patients with ASD. They may provide new insight into the molecular etiology responsible for VSD.

Identification of two novel GATA6 mutations in patients with nonsyndromic conotruncal heart defects.

A Novel GATA6 Mutation in Patients with Tetralogy of Fallot or Atrial Septal Defect

Targeted Sequencing Identifies Novel GATA6 Variants in a Large Cohort of Patients with Conotruncal Heart Defects.

Novel GATA6 Mutations Associated with Congenital Ventricular Septal Defect or Tetralogy of Fallot.

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].

Identification of Functional Mutations in GATA4 in Patients with Congenital Heart Disease

[Novel GATA4 Mutations Identified in Patients with Congenital Heart Disease].

Identification of the novel GATA6 mutation associated with congenital atrial septal defect

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

The mutations ofGATA4andGATA6 in children with isolated atrial septal defect

Somatic Mutations in the GATA6 Gene Underlie Sporadic Tetralogy of Fallot

A Novel Missense Mutation Of Gata4 In A Chinese Family With Congenital Heart Disease

Two novel missense mutations of GATA4 gene in Chinese patients with sporadic congenital heart defects

[A Novel GATA4 Mutation Leading to Congenital Ventricular Septal Defect].

Novel NKX2-5 Mutations Identified in Patients with Congenital Ventricular Septal Defects

Somatic Gata5 Mutations In Sporadic Tetralogy Of Fallot

A Novel Mutation of GATA4 (K319E) is Responsible for Familial Atrial Septal Defect and Pulmonary Valve Stenosis

Gata5 Loss-Of-Function Mutations Underlie Tetralogy Of Fallot

In Silico Analyses Reveal the Relationship Between SIX1/EYA1 Mutations and Conotruncal Heart Defects

Mutation Screening of Gata4 Gene in CTD Patients Within Chinese Han Population.

Investigation of somatic NKX2-5, GATA4 and HAND1 mutations in patients with tetralogy of Fallot.